Ukko is a company that builds a comprehensive, clinically validated map of the molecular structure of food allergies and disorders, acquiring knowledge on the biological mechanisms that drive human food interactions. The company aims to develop foods that are safe and healthy for everyone to eat, starting with two of the most common triggers, peanuts, and wheat.
|HQ||Tel Aviv-Yafo, IL||Map|
|Employees (est.) (Sept 2021)||40||(+9%)|
Ukko total Funding
Ukko latest funding size
Time since last funding
|8 months ago|
|Innovation Endeavors, Khosla Ventures, Fall Line Capital, Continental Grain Company, Leaps by Bayer, Skyviews Life Science, PeakBridge Ventures, TIME Ventures|
Ukko has 79 Twitter Followers. The number of followers has decreased 1.2% month over month and increased 9.7% quarter over quarter
When was Ukko founded?
Ukko was founded in 2016.
Who are Ukko key executives?
Ukko's key executives are Anat Binur and Yanay Ofran.
How many employees does Ukko have?
Ukko has 40 employees.
Who are Ukko competitors?
Competitors of Ukko include Just-Evotec Biologics, Cellink and D&D Pharmatech.
Where are Ukko offices?
Ukko has offices in Tel Aviv-Yafo and Palo Alto.
How many offices does Ukko have?
Ukko has 2 offices.
Receive alerts for 300+ data fields across thousands of companies